Classification ATC Chem. Sub. | ICD-10 | Specialists | Patients’ sex | 2006 | 2007 | 2008 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | % | 95% CI | n | % | 95% CI | n | % | 95% CI | ||||
Benzodiazepine derivative | F20-39, 41 | GER | Men | 470 | 4.0 | 3.6-4.3 | 492 | 4.1 | 3.7-4.4 | 551 | 4.6 | 4.2-4.9 |
 |  | Women | 1218 | 4.1 | 3.9-4.3 | 1302 | 4.4 | 4.2-4.6 | 1378 | 4.7 | 4.5-5.0 | |
N05BA04 | Â | PSYCH | Men | 394 | 3.3 | 3.0-3.7 | 405 | 3.4 | 3.0-3.7 | 413 | 3.4 | 3.1-3.8 |
Oxazepam | Â | Â | Women | 815 | 2.7 | 2.6-2.9 | 785 | 2.6 | 2.5-2.8 | 793 | 2.7 | 2.5-2.9 |
 |  | GP | Men | 8042 | 68.3 | 67.4-69.1 | 8285 | 68.6 | 67.7-69.4 | 8148 | 67.7 | 66.8-68.5 |
 |  |  | Women | 22132 | 74.4 | 73.9-74.9 | 22099 | 74.6 | 74.1-75.0 | 21655 | 74.2 | 73.7-74.7 |
 |  | OTH | Men | 1613 | 13.7 | 13.1-14.3 | 1636 | 13.5 | 12.9-14.1 | 1677 | 13.9 | 13.3-14.5 |
 |  |  | Women | 2929 | 9.8 | 9.5-10.2 | 2905 | 9.8 | 9.5-10.1 | 2816 | 9.6 | 9.3-10.0 |
 |  | WO | Men | 1591 | 13.5 | 12.9-14.1 | 1621 | 13.4 | 12.8-14.0 | 1618 | 13.4 | 12.8-14.0 |
 |  |  | Women | 3462 | 11.6 | 11.3-12.0 | 3462 | 11.7 | 11.3-12.0 | 3419 | 11.7 | 11.3-12.1 |
Benzodiazepine derivative | F20-39, 41 | GER | Men | 262 | 3.5 | 3.1-3.9 | 233 | 3.2 | 2.8-3.6 | 247 | 3.6 | 3.2-4.0 |
 |  | Women | 477 | 3.8 | 3.4-4.1 | 485 | 4.0 | 3.7-4.4 | 481 | 4.1 | 3.8-4.5 | |
N05BA01 | Â | PSYCH | Men | 290 | 3.9 | 3.5-4.3 | 295 | 4.0 | 3.6-4.5 | 280 | 4.1 | 3.6-4.6 |
Diazepam | Â | Â | Women | 415 | 3.3 | 3.0-3.6 | 411 | 3.4 | 3.1-3.7 | 422 | 3.6 | 3.3-4.0 |
 |  | GP | Men | 4820 | 64.6 | 63.6-65.7 | 4799 | 65.8 | 64.7-66.9 | 4501 | 65.7 | 64.6-66.8 |
 |  |  | Women | 9024 | 71.5 | 70.7-72.3 | 8577 | 71.4 | 70.6-72.2 | 8324 | 71.6 | 70.8-72.4 |
 |  | OTH | Men | 1374 | 18.4 | 17.5-19.3 | 1263 | 17.3 | 16.4-18.2 | 1145 | 16.7 | 15.8-17.6 |
 |  |  | Women | 1727 | 13.7 | 13.1-14.3 | 1606 | 13.4 | 12.8-14.0 | 1510 | 13.0 | 12.4-13.6 |
 |  | WO | Men | 902 | 12.1 | 11.4-12.8 | 886 | 12.1 | 11.4-12.9 | 854 | 12.5 | 11.7-13.2 |
 |  |  | Women | 1308 | 10.4 | 9.8-10.9 | 1280 | 10.7 | 10.1-11.2 | 1239 | 10.7 | 10.2-11.2 |
Non-selective monoamine reuptake inhibitor | F20-39 | GER | Men | 125 | 3.6 | 3.0-4.3 | 107 | 3.2 | 2.6-3.7 | 106 | 2.9 | 2.4-3.5 |
 |  | Women | 269 | 3.2 | 2.8-3.5 | 280 | 3.3 | 2.9-3.7 | 276 | 3.2 | 2.8-3.6 | |
 | PSYCH | Men | 101 | 2.9 | 2.4-3.5 | 95 | 2.8 | 2.2-3.4 | 97 | 2.7 | 2.2-3.2 | |
N06AA09 | Â | Â | Women | 269 | 3.2 | 2.8-3.5 | 251 | 2.9 | 2.6-3.3 | 254 | 2.9 | 2.6-3.3 |
Amitriptyline | Â | GP | Men | 2133 | 62.1 | 60.5-63.8 | 2172 | 64.0 | 62.4-65.6 | 2276 | 63.1 | 61.5-64.7 |
 |  |  | Women | 5868 | 69.2 | 68.2-70.2 | 5957 | 70.0 | 69.0-70.9 | 6082 | 70.2 | 69.2-71.1 |
 |  | OTH | Men | 585 | 17.0 | 15.8-18.3 | 553 | 16.3 | 15.1-17.5 | 624 | 17.3 | 16.1-18.5 |
 |  |  | Women | 1038 | 12.2 | 11.5-12.9 | 1100 | 12.9 | 12.2-13.6 | 1133 | 13.1 | 12.4-13.8 |
 |  | WO | Men | 568 | 16.5 | 15.2-17.8 | 531 | 15.7 | 14.4-16.9 | 569 | 15.8 | 14.6-17.0 |
 |  |  | Women | 1254 | 14.8 | 14.0-15.5 | 1143 | 13.4 | 12.7-14.1 | 1145 | 13.2 | 12.5-13.9 |